Haematopoietic stem cell transplantation in children
Survey on haematopoietic stem cell transplantation for children in Europe
Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts
Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
Hematopoietic transplantation for bone marrow failure syndromes and thalassemia
Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions
Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours
Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation
The hope and the reality of reduced intensity transplants in children with malignant diseases
Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning
Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells?
Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future
Immunotherapy in allogeneic hematopoietic stem cell transplantation - not just a case for effector cells
Novel approaches in GVHD therapy
Update on extracorporeal photochemotherapy for graft-versus-host disease treatment
Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity
Late effects after stem cell transplantation (SCT) in children - growth and hormones
Secondary malignancies and quality of life after stem cell transplantation
The polymorphisms −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population
REAL-TIME PCR DETECTION OF HUMAN HERPESVIRUS 6 IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
THE IMPACT OF IMMUNE RECONSTITUTION ON THE DEVELOPMENT OF OPPORTUNISTIC INFECTIONS (OI) AFTER UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION (UUCBT). A MULTIVARIATE ANALYSIS OF HOST, GRAFT, AND DAY +50 IMMUNE PROFILE
T-CELL RECEPTOR (TCR)Vâ REPERTOIRE ANALYSIS, A VALUABLE DIAGNOSTIC TOOL IN SAA AND MDS IN CHILDREN?
ROLE OF NK CELLS IN PEDIATRIC ALL AFTER TRANSPLANTATION OF T CELL DEPLETED ALLOGRAFTS
HIGH NUMBER OF CD34+ CELLS/KG AND CD3+ CELLS/KG HAS NO NEGATIVE IMPACT ON THE INCIDENCE OF SEVERE GvHD IN CHILDREN UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FROM MATCHED OR MISMATCHED UNRELATED
TRANSPLANTATION FROM KIR INCOMPATIBLE DONORS WITH REDUCED INTENSITY CONDITIONING IN PATIENTS WITH RESISTANT LEUKEMIA OR RELAPSE FOLLOWING HLA-IDENTICAL STEM CELL TRANSPLANTATION
PREIMPLANTATION GENETIC DIAGNOSIS INCLUDING HLA TYPING OF EMBRYOS TO ENABLE HLA IDENTICAL CORD BLOOD TRANSPLANTATION IN CONGENITAL ANEMIAS AND IMMUNODEFICIECY DISEASES
ACQUISITION OF COMPLETE DONOR CHIMERISM WITHIN THE FIRST MONTH AFTER ALLOGENEIC PERIPHERAL BLOOD PROGENITOR CELLS TRANSPLANTATION IS ASSOCIATED WITH LOW RISK OF RELAPSE
ROLE OF MRD MONITORING IN ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC TRANSPLANTATION
ALLOGENIC HLA IDENTICAL BONE MARROW TRANSPLANTATION IN PATIENT WITH JUVENILE IDIOPATHIC (CHRONIC) ARTHRITIS (JIA)
DOUBLE THIOTEPA-MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN AND YOUNG ADULTS: TWO TRANSPLANTS FOR THE PRICE OF ONE
ENGRAFTMENT SYNDROME AFTER AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION IN PEDIATRIC PATIENTS: A PROSPECTIVE EVALUATION OF RISK FACTORS AND OUTCOME
UNRELATED CORD BLOOD TRANSPLANT (UCBT) IN CHILDREN WITH SEVERE PRIMARY IMMUNODEFICIENCIES (SPID)
TREOSULFAN-BASED PREPARATIVE REGIMEN FOR SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH ADVANCED HEMATOLOGIC MALIGNANCIES
STEM CELL TRANSPLANTATION FOR EPISTAXIS?
THORACIC KYPHOSIS IN MPS 1 - DOES AGE AT TRANPLANT INFLUENCE OUTCOME?
PULMONARY FUNCTION IMPAIRMENT IN CHILDREN FOLLOWING HEMATOPOETIC STEM CELL TRANSPLANTATION
VERY LONG TERM COMPLICATIONS OF TOTAL BODY IRRADIATION IN CHILDHOOD
INTRODUCTION TO THE PEDIATRIC BLOOD AND MARROW TRANSPLANT CONSORTIUM (PBMTC)
ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE ACQUIRED APLASTIC ANEMI IN CHILDREN. A RETROSPECTIVE STUDY OF SPANISH WORKING PARTY FOR BMT IN CHILDREN (GETMON)
CHILDHOOD PAROXYSMAL NOCTURNAL HEMOGLOBINURIA(PNH) A REPORT OF 8 CASES IN THE NETHERLANDS
ROLE OF PERIPHERAL BLOOD MONONUCLEAR CELL RESPONSES TO RECOMBINANT HUMAN HEAT SHOCK PROTEIN 60 IN PATIENTS WITH OR WITHOUT ACUTE GvHD
PRELIMINARY RESULTS OF THE RETROSPECTIVE STUDY ON THE USE OF FK506 (TACROLIMUS ? PROGRAF) AS SECOND-LINE PROPHYLAXIS-THERAPY AFTER SCT
PERIPHERAL BLOOD MONONUCLEAR CELL RESPONSES TO RECOMBINANT HUMAN HEAT SHOCK PROTEIN 60 IN PATIENT PRE AND POST HAEMATOPOIETIC STEM CELL TRANSPLANT IN ASSOCIATION WITH POSSIBLE BACTERIAL AND/OR FUNGAL STIMULATION
ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) IN PATIENTS (PTS) AFTER REDUCED INTENSITY CONDITIONING (RIC) AND CONVENTIONAL (CON) ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION (ALLO-HSCT)
INFLUENCE OF INTRAVENOUS CYCLOSPORINE INFUSION DURATION ON INCIDENCE AND SEVERITY OF ACUTE AND CHRONIC GVHD IN PAEDIATRIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
EXTRACORPOREAL PHOTOPHERESIS FOR RESISTANT GVHD IN PEDIATRIC PATIENTS: A MONOCENTRIC EXPERIENCE
HEPATIC VENO-OCCLUSIVE DISEASE AFTER PAEDIATRIC HEMOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE MONOCENTRIC EXPERIENCE
VON WILLEBRAND FACTOR-CLEAVING PROTEASE (ADAMTS 13) DECREASES IN THE COURSE OF BONE MARROW TRANSPLANTATION (BMT). EVIDENCE FOR A ROLE IN BMT ASSOCIATED THROMBOTIC MICROANGIOPATHY
CSA VS CSA+MTX IN GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TRANSPLANTED FROM HLA IDENTICAL SIBLING DONORS? SINGLE CENTER ANALYSIS
SUCCESSFUL OUTCOME OF JUVENILE MYELOMONOCYTIC LEUKEMIA RELAPSED AFTER UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION: CASE REPORT OF A PATIENT WITH A LONG-TERM FOLLOW-UP
LYMPHOCYTE SUBSETS IN CHILDREN AFTER ALLOGENIC HSCT
SUCCESSFUL BONE MARROW TRANSPLANTATION FOR X-LINKED LYMPHOPROLIFERATIVE DISEASE: CASE REPORT
DONOR LYMPHOCYTE INFUSIONS FOR GRAFT FAILURE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HURLER SYNDROME: A CASE REPORT
TRANSPLANTATION OF ALLOGENIC CD+-SELECTED STEM CELLS AFTER A FLUDARABINE BASED CONDITIONING REGIMEN FOR CHILDREN WITH MUCOPOLYSACCHARDIDOSIS (M. HURLER)
BROAD PCR-SCREENING FOR VIRAL INFECTIONS IN THE COURSE OF PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANTATION: CLINICAL BENEFIT AND ECONOMIC CONSIDERATIONS
RITUXIMAB FOR PROPHYLAXIS OF EBV REACTIVATION FOLLOWING HCST IN PATIENTS WITH INHERITED METABOLIC STORAGE DISEASES
SEVERE NEUROLOGICAL COMPLICATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
OUTPATIENT AND/OR HOME CARE TREATMENT OF INFECTIVE COMPLICATIONS FOR CHILDREN WITH CANCER
PRE-EMPTIVE THERAPY WITH CIDOFOVIR IN ADENOVIRUS INFECTION AFTER STEM CELL TRANSPLANTATION (SCT) IN CHILDREN
T CELLS CULTURED WITH ADENOVIRUS PEPTIDES RECOGNIZE ADENOVIRUS INFECTED CELLS: AN OPTION FOR IMMUNOTHERAPY?
INVASIVE INFECTION WITH ENTERIC ADENOVIRUS TYPE 40 AND SUCCESSFUL TREATMENT WITH CIDOFOVIR WITHIN FOUR MONTHS AFTER HAPLO-IDENTICAL BONE MARROW TRANSPLANTATION
HUMAN POLYOMA VIRIDAE INFECTION AND ADENOINFECTION IN CHILDREN AND ADOLESCENTS AFTER HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION
INVASIVE FUNGAL INFECTIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN: A SINGLE-CENTER RETROSPECTIVE STUDY
LUNG FUNCTION ABNORMALITIES FOLLOWING BONE MARROW TRANSPLANTATION FOR HOMOZYGOUS BETA-THALASSEMIA ARE NOT SEVERE DESPITE IRON OVERLOAD
ARE GROWTH ABNORMALITIES A PROBLEM IN CHILDREN AFTER HEMATOPOIETIC CELL TRANSPLANTATION?
LATE PULMONARY COMPLICATIONS IN CHIL DREN AND ADOLESCENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
THE RISK OF TRANSPLANT-RELATED TTP/HUS IN CHILDREN IS MARKEDLY INCREASED AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FROM MATCHED UNRELATED DONORS IN CHILDREN? A POSSIBLE GRAFT VS ENDOTHELIAL CELLS EFFECT
EXTRAMEDULLARY RELAPSE OF LEUKEMIA/L YMPHOMA FOLLOWING ALLOGENEIC SCT IN CHILDREN, PRESENTATION AND PROGNOSIS
EVALUATION OF MINIMAL RESIDUAL DISEASE (MRD) IN HEMATOLOGICAL MALIGNANCIES AND POST BMT BY COMBINED SIMULTANEOUS ANALYSIS OF MORPHOLOGY, IMMUNOPHENOTYPING AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
CHEMOTHERAPY VERSUS ALLOGENEIC TRANSPLANTATION IN CHILDHOOD HIGH RISK ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST COMPLETE REMISSION: AN INTERNATIONAL PROSPECTIVE STUDY
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN CHILDREN DIAGNOSED WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION
FEASIBILITY OF CLINICAL-SCALE CD3/CD19 DEPLETION PROCEDURE TO REPLACE CONVENTIONAL CD34 POSITIVE SELECTION
T CELLS RECOVERING EARLY AFTER HAPLOIDENTICAL TRANSPLANTATION OF PURIFIED HEMATOPOIETIC CELLS ARE OF AUTOLOGOUS ORIGIN AND PREDICT IMMINENT SECONDARY GRAFT FAILURE
FEASIBILITY OF HIGH DOSE CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR CELLS RESCUE IN CHILDREN OLDER THAN 3 YEARS WITH HIGH RISK MEDULLOBLASTOMA: RESULTS OF A MONO-INSTITUTIONAL STUDY IN ITALY
HAPLOIDENTICAL STEM CELL TRANSPLANTATION. A COMPARISON OF 3 IMMUNOMAGNETIC SELECTION PROCEDURES
HIGH-DOSE CHEMOTHERAPY WITH BM-(OR STEM CELL) RESCUE FOR CHILDREN WITH ADVANCED (STAGE III-IV) AND RECURRENT EWING'S SARCOMA - A RUSSIAN-BELO-RUSIAN COOPERATIVE STUDY
HEMATOPOIETIC CELL TRANSPLANTATION FOR HURLER SYNDROME AND OTHER INBORN ERRORS: LESSONS LEARNED, UNANSWERED QUESTIONS, AND FUTURE DIRECTIONS
THE ULTIMATE OPPORTUNIST: ACANTHAMOEBA CASTELLANI ENCEPHALITIS FOLLOWING PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR DYSKERATOSIS CONGENITA
ALLOGENEIC BONE MARROW TRANSPLANTATION FOR JUVENILE MYELOMONOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE ON 23 PATIENTS
HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA IN FANCONI ANEMIA
USEFULNESS OF QUANTITATIVE PCR ANALYSIS OF HEMATOPOIETIC CHIMERISM FOR EARLY DIAGNOSIS OF RELAPSE IN CHILDREN WITH LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED SIBLING DONOR